SXTP 60 Degrees Pharmaceuticals, Inc
$0.85▲ +14.46%
Healthcare
Other
After hours
$0.79▼ -6.72%
Oct 28, 7:49 PM ET
Volume 1.98M
Avg Volume (10D) 1.66M
Key Metrics & Fundamentals
Market Cap
$2.98M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.59 - 8.62
% vs 50 MA
-16.81%
% vs 200 MA
-52.52%
RSI-14
42.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.22
Free Cash Flow
-$2.32M
Gross Rev
$207,898
Gross Profit
$56,798
EBITDA
-$2.23M
COGS
$151,100
Operating Exp
$2.33M
Operating Income
-$2.27M
EBIT
-$2.27M
Pretax Income
-$2.27M
Net Income
-$2.26M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News
60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
GlobeNewswire · Oct 28, 2026 8:30 AM ET
60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients
GlobeNewswire · Oct 27, 2026 8:06 AM ET
60 Degrees Pharmaceuticals Sets January 2027 Babesiosis Data Readout and Plans FDA Pre-sNDA Meeting
InvestorsHub · Oct 6, 2026 10:44 AM ET
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
GlobeNewswire · Oct 6, 2026 8:10 AM ET
60 Degrees Pharmaceuticals and Exyn Technologies Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ACCESS Newswire · Oct 2, 2026 9:00 AM ET
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
GlobeNewswire · Oct 1, 2026 8:03 AM ET
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 8:04 AM ET
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
GlobeNewswire · Aug 14, 2026 3:47 PM ET
Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 10, 2026 8:05 PM ET
Merck KGaA (MKKGY) Misses Q2 Earnings Estimates
Zacks · Aug 6, 2026 7:10 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SXTP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.